Patents by Inventor Chris W. Mahne

Chris W. Mahne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11723945
    Abstract: Methods for treating psychiatric and psychological diseases or conditions, including depression, by use of L-tryptophan or a derivative or analog thereof and a derivative of phyllokinin are described. The methods can be used together with other agents for treatment of depression or other psychiatric or psychological diseases or conditions. Pharmaceutical compositions comprising at least one of L-tryptophan or a derivative or analog thereof and a derivative of phyllokinin together with a pharmaceutically acceptable excipient are also described. The pharmaceutical compositions can include other therapeutically active agents for the treatment of psychiatric or psychological diseases or conditions such as depression.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: August 15, 2023
    Inventor: Chris W. Mahne
  • Publication number: 20210275623
    Abstract: Methods for treating psychiatric and psychological diseases or conditions, including depression, by use of L-tryptophan or a derivative or analog thereof and a derivative of phyllokinin are described. The methods can be used together with other agents for treatment of depression or other psychiatric or psychological diseases or conditions. Pharmaceutical compositions comprising at least one of L-tryptophan or a derivative or analog thereof and a derivative of phyllokinin together with a pharmaceutically acceptable excipient are also described. The pharmaceutical compositions can include other therapeutically active agents for the treatment of psychiatric or psychological diseases or conditions such as depression.
    Type: Application
    Filed: April 23, 2018
    Publication date: September 9, 2021
    Inventors: Chris W. MAHNE, Hasib SALAH-UDDIN
  • Publication number: 20190374525
    Abstract: The present invention describes small molecules that have the activity of directly enhancing insulin sensitivity through epigenetic regulation. These small molecules, therefore, provide a new path for the treatment of type 2 diabetes and insulin resistance in type 1 diabetes or prediabetes and also can be used to treat obesity and chronic liver disease. Methods and compositions including these small molecules or for their administration are described. The methods and compositions can include additional anti-diabetic agents.
    Type: Application
    Filed: February 6, 2018
    Publication date: December 12, 2019
    Inventors: Chris W. MAHNE, Hasib SALAH-UDDIN
  • Patent number: 6981141
    Abstract: An encryption method that is largely transparent to a user is accomplished by intercepting a change document or open document command, carrying out an encryption or decryption process, and then completing the command on an encrypted or decrypted file. The encryption method can be used in a wide variety of environments, such as an individual computer program, a database or electronic messaging over the Internet. The encryption method can select from a plurality of encryption algorithms. The encryption method can also allow just a portion of a document to be encrypted, placed in a container, and then be represented by an object linking and embedding (“OLE”) container object or other representation supported by the file.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: December 27, 2005
    Assignee: MAZ Technologies, Inc
    Inventors: Chris W. Mahne, Steve Zizzi, Shannon Von Burns, Ken Townsley